Precio FOB
Obtener el precio más reciente|
- Minimum Order
País:
China
N º de Modelo:
-
Precio FOB:
Lugar de origen:
-
Precio de pedido mínimo:
-
Cantidad de pedido mínimo:
-
Detalle de embalaje:
-
El tiempo de entrega:
-
Capacidad de suministro:
-
Tipo de pago:
-
Grupo de productos :
-
Persona de contacto Dong
Road Lingong, Linyi, Shandong
On December *5, ***5, the United States Food and Drug Administration (FDA) approved BRIDION® (Sugammadex) injection for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults undergoing surgery. Doses and timing of BRIDION administration should be based on monitoring for twitch responses and the extent of spontaneous recovery that has occurred. Administer BRIDION intravenously as a single bolus injection. The bolus injection may be given over *0 seconds, into an existing intravenous line. BRIDION can be used to reverse different levels of rocuronium- or vecuronium-induced neuromuscular blockade. The approved recommended BRIDION dosages are listed below. The use of lower than recommended doses of BRIDION may lead to an increased risk of recurrence of neuromuscular blockade after initial reversal and is not recommended.
| País: | China |
| N º de Modelo: | - |
| Precio FOB: | Obtener el precio más reciente |
| Lugar de origen: | - |
| Precio de pedido mínimo: | - |
| Cantidad de pedido mínimo: | - |
| Detalle de embalaje: | - |
| El tiempo de entrega: | - |
| Capacidad de suministro: | - |
| Tipo de pago: | - |
| Grupo de productos : | - |
